Review



cells mt 2 u87 cd4 cxcr4 ccr5 and cemx174 5 25 m7 cells  (Yeasen Biotechnology)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Yeasen Biotechnology cells mt 2 u87 cd4 cxcr4 ccr5 and cemx174 5 25 m7 cells
    Inhibitory activity of ADS-J21 on infection by primary HIV-1 strain pseudovirus. Briefly, ADS-J21 were mixed with 50 µL of the pseudovirus about 100 TCID 50 before the mixtures were added to <t>the</t> <t>U87.CD4.CCR5.CXCR4</t> cells, then incubated at 37 °C for 30 min. After 2 days, the cells were lysed and measured for luciferase activity as described above. ( A ) subtype A, ( B ) subtype B, ( C ) subtype C, ( D ) subtype C/D, ( E ) subtype D. Single-cycle infection experiments were performed as described in Materials and Methods. ( F ) Laboratory strains. Each sample was tested in triplicate and the experiment was repeated twice. The data from one representative experiment are presented in mean ± standard deviation.
    Cells Mt 2 U87 Cd4 Cxcr4 Ccr5 And Cemx174 5 25 M7 Cells, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cells mt 2 u87 cd4 cxcr4 ccr5 and cemx174 5 25 m7 cells/product/Yeasen Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    cells mt 2 u87 cd4 cxcr4 ccr5 and cemx174 5 25 m7 cells - by Bioz Stars, 2024-12
    86/100 stars

    Images

    1) Product Images from "ADS-J21 is a novel HIV-1 entry inhibitor targeting gp41"

    Article Title: ADS-J21 is a novel HIV-1 entry inhibitor targeting gp41

    Journal: Current Research in Microbial Sciences

    doi: 10.1016/j.crmicr.2024.100260

    Inhibitory activity of ADS-J21 on infection by primary HIV-1 strain pseudovirus. Briefly, ADS-J21 were mixed with 50 µL of the pseudovirus about 100 TCID 50 before the mixtures were added to the U87.CD4.CCR5.CXCR4 cells, then incubated at 37 °C for 30 min. After 2 days, the cells were lysed and measured for luciferase activity as described above. ( A ) subtype A, ( B ) subtype B, ( C ) subtype C, ( D ) subtype C/D, ( E ) subtype D. Single-cycle infection experiments were performed as described in Materials and Methods. ( F ) Laboratory strains. Each sample was tested in triplicate and the experiment was repeated twice. The data from one representative experiment are presented in mean ± standard deviation.
    Figure Legend Snippet: Inhibitory activity of ADS-J21 on infection by primary HIV-1 strain pseudovirus. Briefly, ADS-J21 were mixed with 50 µL of the pseudovirus about 100 TCID 50 before the mixtures were added to the U87.CD4.CCR5.CXCR4 cells, then incubated at 37 °C for 30 min. After 2 days, the cells were lysed and measured for luciferase activity as described above. ( A ) subtype A, ( B ) subtype B, ( C ) subtype C, ( D ) subtype C/D, ( E ) subtype D. Single-cycle infection experiments were performed as described in Materials and Methods. ( F ) Laboratory strains. Each sample was tested in triplicate and the experiment was repeated twice. The data from one representative experiment are presented in mean ± standard deviation.

    Techniques Used: Activity Assay, Infection, Incubation, Luciferase, Standard Deviation

    In vitro cytotoxicity of ADS-J21 and ADS-J1. <xref ref-type= a " title="In vitro cytotoxicity of ADS-J21 and ADS-J1.a" property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: In vitro cytotoxicity of ADS-J21 and ADS-J1. a

    Techniques Used: In Vitro



    Similar Products

    cells mt 2 u87 cd4 cxcr4 ccr5 and cemx174 5 25 m7 cells  (Yeasen Biotechnology)
    86
    Yeasen Biotechnology cells mt 2 u87 cd4 cxcr4 ccr5 and cemx174 5 25 m7 cells
    Inhibitory activity of ADS-J21 on infection by primary HIV-1 strain pseudovirus. Briefly, ADS-J21 were mixed with 50 µL of the pseudovirus about 100 TCID 50 before the mixtures were added to <t>the</t> <t>U87.CD4.CCR5.CXCR4</t> cells, then incubated at 37 °C for 30 min. After 2 days, the cells were lysed and measured for luciferase activity as described above. ( A ) subtype A, ( B ) subtype B, ( C ) subtype C, ( D ) subtype C/D, ( E ) subtype D. Single-cycle infection experiments were performed as described in Materials and Methods. ( F ) Laboratory strains. Each sample was tested in triplicate and the experiment was repeated twice. The data from one representative experiment are presented in mean ± standard deviation.
    Cells Mt 2 U87 Cd4 Cxcr4 Ccr5 And Cemx174 5 25 M7 Cells, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cells mt 2 u87 cd4 cxcr4 ccr5 and cemx174 5 25 m7 cells/product/Yeasen Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    cells mt 2 u87 cd4 cxcr4 ccr5 and cemx174 5 25 m7 cells - by Bioz Stars, 2024-12
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Inhibitory activity of ADS-J21 on infection by primary HIV-1 strain pseudovirus. Briefly, ADS-J21 were mixed with 50 µL of the pseudovirus about 100 TCID 50 before the mixtures were added to the U87.CD4.CCR5.CXCR4 cells, then incubated at 37 °C for 30 min. After 2 days, the cells were lysed and measured for luciferase activity as described above. ( A ) subtype A, ( B ) subtype B, ( C ) subtype C, ( D ) subtype C/D, ( E ) subtype D. Single-cycle infection experiments were performed as described in Materials and Methods. ( F ) Laboratory strains. Each sample was tested in triplicate and the experiment was repeated twice. The data from one representative experiment are presented in mean ± standard deviation.

    Journal: Current Research in Microbial Sciences

    Article Title: ADS-J21 is a novel HIV-1 entry inhibitor targeting gp41

    doi: 10.1016/j.crmicr.2024.100260

    Figure Lengend Snippet: Inhibitory activity of ADS-J21 on infection by primary HIV-1 strain pseudovirus. Briefly, ADS-J21 were mixed with 50 µL of the pseudovirus about 100 TCID 50 before the mixtures were added to the U87.CD4.CCR5.CXCR4 cells, then incubated at 37 °C for 30 min. After 2 days, the cells were lysed and measured for luciferase activity as described above. ( A ) subtype A, ( B ) subtype B, ( C ) subtype C, ( D ) subtype C/D, ( E ) subtype D. Single-cycle infection experiments were performed as described in Materials and Methods. ( F ) Laboratory strains. Each sample was tested in triplicate and the experiment was repeated twice. The data from one representative experiment are presented in mean ± standard deviation.

    Article Snippet: The cytotoxicity of ADS-J21 and ADS-J1 in cells (MT-2, U87.CD4.CXCR4.CCR5 and CEMx174 5.25M7 cells) was tested using the CCK-8 kit (YEASEN).

    Techniques: Activity Assay, Infection, Incubation, Luciferase, Standard Deviation

    In vitro cytotoxicity of ADS-J21 and ADS-J1. <xref ref-type= a " width="100%" height="100%">

    Journal: Current Research in Microbial Sciences

    Article Title: ADS-J21 is a novel HIV-1 entry inhibitor targeting gp41

    doi: 10.1016/j.crmicr.2024.100260

    Figure Lengend Snippet: In vitro cytotoxicity of ADS-J21 and ADS-J1. a

    Article Snippet: The cytotoxicity of ADS-J21 and ADS-J1 in cells (MT-2, U87.CD4.CXCR4.CCR5 and CEMx174 5.25M7 cells) was tested using the CCK-8 kit (YEASEN).

    Techniques: In Vitro